Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02956291 · ClinicalTrials.gov registry record · NA
Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors
A NA study of Brain Tumor, sponsored by Case Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 172
- Enrollment target
- 1
- Study location
NCT02956291 is a NA study of Brain Tumor that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 172 participants, below the 279-participant average among 69 other Brain Tumor trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02956291, a NA study of Brain Tumor, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research study is to test new methods that could improve diagnosis and assessment of brain tumors. One of these methods is a new MR (magnetic resonance) imaging technique called magnetic resonance fingerprinting (MRF), which allows for rapidly scanning the patient and provides quantitative information on tumor tissue. The investigators will compare the data gathered from MR Fingerprinting with other imaging tests, clinical information, treatment details and biopsy results to evaluate the accuracy of this new technique.
Conditions Studied
Interventions
- DEVICE Magnetic Resonance Fingerprinting
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02956291
The ClinicalTrials.gov registry entry for NCT02956291 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 279-participant average among 69 other Brain Tumor trials with a reported enrollment target (38% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Fingerprinting is the first listed.
NCT02956291 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02956291 about?
NCT02956291 is a clinical study titled "Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors". The purpose of the research study is to test new methods that could improve diagnosis and assessment of brain tumors. One of these methods is a new MR (magnetic resonance) imaging technique called magnetic resonance fingerprinting (MRF), which allows for rapidly scanning the patient and provides qua...
What is the current status of trial NCT02956291?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2017-02-15. Estimated completion is 2026-06.
What conditions does trial NCT02956291 study?
This clinical trial studies the following conditions: Brain Tumor.
What interventions are being tested in trial NCT02956291?
The interventions under investigation include: Magnetic Resonance Fingerprinting (DEVICE).
Who is sponsoring clinical trial NCT02956291?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02956291 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors
RECRUITING · NA
-
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
RECRUITING · NA
-
Ommaya Reservoir Placement for Brain Tumor Biomarker Access
RECRUITING · NA
-
Mapping of Human Cognition
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.